LLY · Eli Lilly and Company

NYSE · Healthcare · Drug Manufacturers—General

Pullback Candidate
This service is a stock screening tool only and does not provide financial advice. 본 서비스는 투자 판단을 돕기 위한 스크리닝 도구이며, 투자 자문이 아닙니다.

Score

8.5

Price

$852.7

52-week drawdown

-12.3%

ATH drawdown

-12.3%

Price chart

Revenue and net income

Score breakdown

revenueGrowth100/100
netIncomeGrowth100/100
drawdownAttractiveness78/100
priceMomentum55/100
valuation56/100
stabilityRisk96/100

Key risks

  • No major rule-based risk flag in the current dataset.

Data last updated: 2026-06-21T22:15:00.000Z